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Samaja, Michele, Sonia Allibardi, Giuseppina
Milano, Gabriella Neri, Bruno Grassi, L. Bruce Glad-
den, and Michael C. Hogan. Differential depression of
myocardial function and metabolism by lactate and H1. Am.
J. Physiol. 276 (Heart Circ. Physiol. 45): H3–H8, 1999.—The
effects of both high blood H1 concentration ([H1]) and high
blood lactate concentration ([lactate]) under ischemia-
reperfusion conditions are receiving attention, but little is
known about their effects in nonischemic hearts. Isolated rat
hearts were Langendorff perfused at constant flow with
media at two pH values (7.4 and 7.0) and two [lactate] (0 and
20 mM) in various sequences (n 5 6/group). Coronary flow
and arterial O2 content were kept constant at levels that
allowed hearts to function without O2 supply limitation. We
measured contractility, O2 uptake, diastolic pressure, and at
the end of the protocol, tissue [lactate] and pH. Perfusion with
high [lactate] raised tissue [lactate] from 5.5 6 0.1 to 17.5 6
2.6 µmol/heart (P , 0.0001), whereas decreasing the pH of
the medium decreased tissue pH from 6.94 6 0.02 to 6.81 6
0.06 (P 5 0.002). Heart rate was not affected by high [lactate]
but was reversibly depressed by high [H1] (P 5 0.004).
Developed pressure declined by 20% in response to high
[lactate], high [H1], and high [lactate] 1 high [H1] (P 5
0.002). After the high-[lactate] challenge was withdrawn,
pressure continued to decline. In contrast, withdrawing the
high [H1] challenge allowed partial recovery. The behavior of
diastolic pressure mirrored that of developed pressure. Al-
though unaffected by high [lactate], the O2 uptake was
reversibly depressed by high [H1]. This suggests higher O2
cost per contraction in the presence of high [lactate]. We
conclude that for similar acute contractility depression, high
[lactate] induces irreversible damage, likely at some point in
the pathway of O2 utilization. In contrast, the effect of high
[H1] appears reversible. These differential behaviors may
have implications for heart function during heavy exercise
and ischemia-reperfusion events.
myocardial performance; isolated heart; pH
DURING MYOCARDIAL ISCHEMIA, lactic acid accumulates in
the cell cytosol as a consequence of the switch from
aerobic to anaerobic metabolism. The subsequent H1
load activates several mechanisms that ultimately
impair myocardial function (1, 16). One of these mecha-
nisms is the inhibition of certain key enzymes of
glycolysis by H1 (18). Although this mechanism inhib-
its myocardial performance, it may turn out to be
protective during reperfusion of ischemic tissue, be-
cause it decreases tissue energy needs, thereby enhanc-
ing myocardial recovery (11, 19, 21).
There are instances unrelated to ischemia, e.g., heavy
exercise, when blood lactate concentration ([lactate])
may reach 20 mM (10). This raises the issue of whether
or not such a high [lactate] may become relevant for
heart contractility even under normal perfusion condi-
tions. A significant question is to what extent the
possible effects are caused by the lactate anion versus
H1. Hogan et al. (13) reported that high [lactate] and
high blood H1 concentration ([H1]) independently de-
press contractility in working dog muscle. Andrews et
al. (3) showed a biphasic specific effect of L(1)-lactate
(maximal at [lactate] 5 25 mM) on Ca21-activated force
in cardiac papillary fibers independent of pH. Cairns et
al. (5) found that exposure of myocytes to 20 mM
[lactate] exacerbates the intracellular Ca21 load in-
duced by acidosis. Studies in ischemic-reperfused, iso-
lated hearts show that lactate, and not H1, contributes
to the postischemic damage (8). Indeed, in that model,
hearts did not recover at all from ischemia when
perfused with 10 mM [lactate]. Although this observa-
tion can be explained with increased lactate-to-pyru-
vate and hence NADH-to-NAD1 ratios, it appears
important to assess whether high [lactate] and/or high
[H1] may impair cardiac function independently of
ischemia-reperfusion. The aim of this study was there-
fore to test the separate effects of elevated levels of high
[lactate] and high [H1] in normally perfused hearts,
thereby excluding the potentially confounding effects of
ischemia.
MATERIALS AND METHODS
Apparatus. Rat hearts were Langendorff perfused with
Krebs-Henseleit media containing varying amounts of lactate
and H1. Salts (Sigma Diagnostics, St. Louis, MO) were of the
highest available purity, and care was taken to maintain near
constant ionic strength (Table 1). The media were equili-
brated in membrane oxygenators at PO2 5 619 6 18 mmHg
(mean 6 SE) and PCO2 5 43 6 1 mmHg. A peristaltic pump
(Gilson, Villiers Le Bel, France) delivered the medium at fixed
flow (15 ml/min) to an 8-µm-pore size filter (Nucleopore,
Pleasanton, CA), the preheater, and the aortic cannula. All
the components of the perfusion system were kept at 37°C by
an external water bath (Endocal, Neslab Instruments, New-
ington, NH).
Heart perfusion. Male Sprague-Dawley rats fed ad libitum
(wt 250–280 g) were anesthetized with an intraperitoneal
injection of heparinized thiopental sodium (10 mg/100 g body
wt). Hearts (average wt 0.90 6 0.05 g) were rapidly excised,
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immersed in isotonic saline solution (20°C), and mounted on
the system. A saline-filled latex balloon, introduced into the
left ventricle, was connected to a pressure transducer (model
52–9966, Harvard Apparatus, Natick, MA) to measure end-
diastolic pressure (EDP), left ventricular developed pressure
(LVDP), maximal rate of contraction (1dP/dtmax) and relax-
ation (2dP/dtmax), and heart rate (HR). Coronary perfusion
pressure (CPP) was monitored by an additional transducer
connected to the aortic cannula. Venous return was collected
from the pulmonary artery to measure venous PO2 (model
5300 Oxygen Monitor, YSI, Yellow Springs, OH) and hence O2
uptake (V˙O2).
Protocols. Hearts were stabilized for 30 min with pH 7.4,
zero-lactate buffer (baseline). During this period, the balloon
volume was adjusted to achieve EDP < 10 mmHg and was
kept constant for the remainder of the experiment. After
control measurements, the perfusing medium was changed in
various sequences (Table 2). To determine tissue pH and
tissue [lactate] at the end of the last period, some hearts were
freeze-clamped with tongs previously cooled in liquid nitro-
gen and were stored at 280°C until analysis.
Biochemical analyses. The heart was removed from liquid
nitrogen, and a small sample (,100 mg) was quickly cut from
the lower left ventricle. The sample was weighed, frozen, and
homogenized in a medium (10 µl/mg) containing (in mM) 145
KCl, 10 NaCl, and 5 iodoacetic acid, pH 7.0 (7). The mixture
was subjected to repeated grinding with a ground-glass rod in
ice water. For tissue pH analysis, an aliquot of the homog-
enized sample was immediately analyzed using a blood
gas-pH analyzer (Ciba Corning M238, Milan, Italy) (7). The
remainder was used for tissue lactate analysis by enzymatic
methods (ESAT 6661, Eppendorf, Hamburg, Germany).
Statistics. Data are expressed as means 6 SE. To detect
significant differences, we used the two-tailed Student’s t-test
for paired and unpaired observations as appropriate. The
level of significance was set at P , 0.05.
RESULTS
The pH measured in the arterial inflow and in the
venous effluent, as well as tissue pH and tissue [lac-
tate], are reported in Table 3. Table 4 reports myocar-
dial performance during control perfusion. Figure 1
shows the performance before, during, and after a
lactate (group 3) or H1 challenge (groups 1 and 2
combined) for periods 1–3 of Table 2. The significance of
the effects of high [lactate] and high [H1] is tested
against the first control condition, unless otherwise
stated. Some parameters were not in a steady state at
the end of the 10-min H1 or lactate challenge, so final
values were used to indicate effects.
LVDP declined to 81 and 80% of control for the lactate
and H1 challenges, respectively (P 5 0.002 for both).
On return to control conditions, H1-challenged hearts
partially recovered LVDP (P 5 0.02 vs. control), whereas
LVDP continued to decline steadily (P 5 0.005 vs.
control, Fig. 1A) in lactate-challenged hearts. The
responses of 1dP/dtmax and 2dP/dtmax (not shown) are
superimposable on those shown for LVDP.
HR was depressed by high [H1] (P 5 0.004 vs.
control) but not by high [lactate] [P 5 not significant
(NS) vs. control, Fig. 1B]. On return to control condi-
Table 1. Composition of media
Nominal pH 7.4 Nominal pH 7.0
0 mM lactate 20 mM lactate 0 mM lactate 20 mM lactate
Salt, mM
NaCl 116.0 92.8 129.9 111.4
KCl 4.7 4.7 4.7 4.7
Na2SO4 1.2 1.2 1.2 1.2
Na2-EDTA 0.5 0.5 0.5 0.5
MgCl2 1.2 1.2 1.2 1.2
CaCl2 2.5 2.5 2.5 2.5
KH2PO4 1.2 1.2 1.2 1.2
NaHCO3 25.0 25.0 9.0 9.0
Glucose 11.0 11.0 11.0 11.0
Na-lactate 0.0 20.0 0.0 20.0
NaOH 1.0 1.0 1.0 1.0
Ions, mM
Na1 145.4 142.2 143.3 144.8
K1 5.9 5.9 5.9 5.9
Ca21 2.5 2.5 2.5 2.5
Cl2 123.1 99.9 137.0 118.5
Osmolarity, mosM
309.7 303.3 305.5 308.4
Table 2. Sequence of perfusing media
Group n
Period
1
(30 min)
2
(10 min)
3
(15 min)
4
(10 min)
5
(10 min)
1 5 0/7.4 0/7.0 0/7.4 20/7.4 20/7.0
Control >H1 Control >Lactate >Lactate1>H1
2 6 0/7.4 0/7.0 0/7.4 20/7.0 20/7.0
Control >H1 Control >Lactate1>H1 >Lactate
3 5 0/7.4 20/7.4 0/7.4
Control >Lactate Control
Numbers separated by slash refer to lactate concentration ([lactate], in mM) followed by arterial perfusate pH.
Table 3. Values for arterial, venous, and tissue pH and
tissue lactate concentration
Nominal Arterial pH
7.4 7.0
0 mM
arterial
[lactate]
20 mM
arterial
[lactate]
0 mM
arterial
[lactate]
20 mM
arterial
[lactate]
Arterial pH 7.3460.01 7.3460.01 6.9860.01 6.9860.01
Venous pH 7.2460.01 7.2460.01 6.9060.01 6.9060.01
Tissue pH 6.9760.02 6.9160.02 NA 6.8160.03
Tissue lactate, mM 5.560.1 16.861.4 NA 19.161.0
Values are means 6 SE; n 5 4–6 hearts/group. [lactate], Lactate
concentration; NA, not applicable.
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tions, HR was the same as in controls for both groups
(P 5 NS).
LVDP·HR, an index of heart energy expenditure,
declined to 70 and 75% of control for the lactate and H1
challenges, respectively (P 5 0.001 for both). On return
to control conditions, H1-challenged hearts partially
recovered LVDP·HR (P 5 0.03 vs. control), whereas
LVDP·HR continued to decline steadily in lactate-
challenged hearts (P 5 0.002 vs. control, Fig. 1C).
V˙O2 was not affected by high [lactate] (Fig. 1D, P 5
NS) but was decreased by high [H1] (P , 0.0001). On
return to control conditions, V˙O2 fell in lactate-
challenged hearts (P 5 0.03 vs. control), as opposed to
complete recovery in H1-challenged hearts (P 5 NS vs.
control).
The effects of high [H1] and high [lactate] were
comparable for both EDP (P 5 0.05, Fig. 1E) and CPP
(P 5 0.003, Fig. 1F). On return to control conditions,
H1-challenged hearts maintained diastolic contracture
and vascular resistance, but these parameters were
more compromised in lactate-challenged hearts (P 5
0.05 between groups).
To gain further insight into possible mechanisms of
action, we exposed hearts that had recovered from the
H1 challenge to high [lactate], with and without high
[H1] in alternate sequences (periods 4 and 5 of Table 2).
The performance of lactate-challenged hearts was too
unstable to allow further use. Data in Fig. 2 are
expressed as a percentage of the value measured after
recovery from high [H1] (period 3 in Table 2); therefore,
each heart served as its own control. Increase of
[lactate] or [lactate] 1 [H1] depressed LVDP by 19 and
21%, respectively, as in Fig. 1A. Combining high [H1]
and high [lactate] caused further depression of LVDP,
but removing the excess H1 from the lactate-H1 chal-
lenge caused no further deterioration of contractility.
High [lactate] alone did not depress HR, as already
shown in Fig. 1B, but high [lactate] 1 high [H1]
significantly (P , 0.0001) depressed HR (Fig. 2B).
Finally, V˙O2 appeared to be unaffected by high [lactate]
alone, but high [lactate] 1 high [H1] significantly
depressed V˙O2.
DISCUSSION
General considerations and comparison to in vivo
situation. In this study, we addressed the separate roles
of lactate and H1 on myocardial function. We found
that both high [lactate] and high [H1] depress myocar-
dial function independently of each other. However, for
similar acute depressions of contractility, high [lactate]
induces irreversible damage. In contrast, the effect of
high [H1] appears reversible. Because these observa-
tions relate to isovolumic, denervated hearts perfused
at constant flow with blood-free media, interference by
nervous or humoral factors or by different loading
conditions is ruled out.
In humans, systemic [lactate] can transiently reach
.20 mM values during heavy exercise (10) without
detrimental effects on cardiac function. Indeed, myocar-
dial contractility is often increased during exercise.
Table 4. Performance and metabolism during
control perfusion
Developed pressure, mmHg 130.766.9
1dP/dtmax, mmHg/s 3,7726231
2dP/dtmax, mmHg/s 1,868694
Heart rate, min21 26164
Developed pressure·heart rate, mmHg·min21 ·1023 34.0361.87
Diastolic pressure, mmHg 13.660.8
Perfusion pressure, mmHg 8566
Venous PO2, mmHg 228615
O2 uptake, µmol/min 9.2960.31
Venous pH 7.2260.01
Venous PCO2, mmHg 5861
Values are means 6 SE; n 5 16 hearts. Conditions of control
perfusion: 0 lactate; PO2 5 619 6 18 mmHg; PCO2 5 43 6 1 mmHg;
pH 5 7.34 6 0.01. 1dP/dtmax, maximal rate of contraction; 2dP/dtmax,
maximal rate of relaxation.
Fig. 1. Time course of changes (from
top to bottom, left to right) in developed
pressure (A), heart rate (B), developed
pressure [multi] heart rate (C), oxygen
uptake (D), end-diastolic pressure (E),
and perfusion pressure (F) during peri-
ods 1–3 of Table 2. H1 (n 5 11 hearts,
k) and lactate (n 5 5 hearts, r) chal-
lenges were given from t 5 20 min
through t 5 30 min. Statistical tests
performed at end of various periods:
*P , 0.05 vs. baseline control perfu-
sion.
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However, exercise is a multifactorial environment, and
heart contractility is the overall result of the interac-
tion of many changing variables, e.g., increased blood
K1, Ca21, and catecholamines (15, 17). Therefore, it is
not surprising that the separate effects of high [H1] and
high [lactate] observed in this study, ruling out interfer-
ence from other factors known to influence contractility,
do not follow the in vivo trends. For example, in vivo
changes in plasma Ca21 have already been shown to
effectively protect hearts from lactic acidosis (15). Ac-
cordingly, other factors must be important in offsetting
the detrimental effects of high [lactate] and/or high
[H1]. Additional studies are required to tease apart the
separate and interactive effects of the various compo-
nents that ultimately determine cardiac performance
during exercise.
Critique of experimental model. Care was taken to
minimize ion composition and strength changes when
varying [lactate] and [H1]. Constant coronary flow and
arterial PO2 imply unaltered O2 supply, which was
calculated to be 14.1 µmol/min throughout. This value
is slightly higher than the O2 supply of in vivo hearts
(8.5–10.1 µmol/min, when assuming coronary flow 5
70–85 ml·100 g21 ·min21, [Hb] 5 15.5 g/dl, and 98% O2
saturated at arterial PO2 5 100 mmHg; Ref. 4). There-
fore, factors linked to inadequate convective O2 delivery
are minimized or eliminated.
The homogenate technique is an accurate and practi-
cal method for the estimation of intracellular pH (7)
because measurements of tissue pH by biochemical and
31P magnetic resonance spectroscopy methods are highly
correlated (20). The values for venous and tissue pH
closely reflect the changes in [H1] in the perfusing
medium. Decreasing arterial pH from 7.34 to 6.98
corresponds to an increase in [H1] of 59 nM. This
increase in arterial [H1] causes a tissue [H1] increase
by 41 nM, equivalent to a tissue pH decrease from 6.94
(average of all measurements with arterial pH 5 7.34)
to 6.81 (tissue pH for arterial pH 5 7.34).
Tissue [lactate] also reflects the changes of [lactate]
in the perfusing medium. Perfusing hearts with 20 mM
[lactate] induces a threefold rise of tissue [lactate].
Tissue [lactate] is an integrated index of both endog-
enous lactate production and exogenous lactate addi-
tion. Furthermore, it represents the average of intracel-
lular and interstitial [lactate]. Therefore, these data
certainly do not provide any quantitative information
regarding lactate uptake.
Ex vivo myocardial responses to high [lactate] and
high [H1]. Because the heart is not a homogeneous
tissue, it is not surprising that the same lactate or H1
loads cause different responses in the various tissues
that constitute the myocardial mass. Although a cer-
tain degree of interaction among the various tissues is
expected in ex vivo models, some features of the model
used here allow a discussion of the effects of lactate or
H1 in the various tissues.
The conducting system, the performance of which is
best marked by HR changes, is influenced by H1 but not
by lactate. This finding is in agreement with the studies
by Karmazyn (14) and Cross et al. (8). In the present
study, an H1 load induces reversible HR depression,
both in the absence (Fig. 1) and in the presence (Fig. 2)
of a lactate load.
Because the volume of the intraventricular balloon is
fixed at the start of the perfusion, EDP raises proportion-
ally to diastolic contracture. This stems from impaired
Ca21 sequestration into the sarcoplasmic reticulum
secondary to low available ATP (2). EDP is influenced
by lactate and H1 in similar amounts. When [H1] is
restored to normal in the medium, EDP stabilizes, as
opposed to steadily increasing when lactate is removed
from the medium. The finding that high [lactate] may
induce irreversible damage to the Ca21-sequestration
system is consistent with the hypothesis that glycolytic
ATP is crucial to maintain Ca21 homeostasis (23) and
thus that lactate-induced inhibition of glycolysis im-
pairs the Ca21-pumping mechanisms. Our finding is
Fig. 2. Behavior of hearts recovered from H1 challenge when exposed to high [lactate] alone and high [lactate] 1
high [H1] (n 5 5 hearts, r) or high [lactate] 1 high [H1] and high [lactate] alone (n 5 6 hearts, n). Data are
expressed as percentage of value at end of recovery from H1 challenge.
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supported by the observation that cardiac myocytes
exposed to 20 mM lactate went into severe contrac-
ture (5).
In this model with constant coronary flow, the changes
in vascular resistance are best characterized by changes
in CPP. Like EDP, CPP is influenced by lactate and H1
in similar amounts. Likewise, when normal [H1] is
restored CPP stabilizes, as opposed to steadily increas-
ing when lactate is removed from the medium. Al-
though this might suggest irreversible damage inferred
to the endothelium by lactate, the increased vascular
resistance may be secondary to myocardial stiffness
originated by diastolic contracture (22).
A major constituent of the myocardium, the contrac-
tile system, is best assessed by both LVDP and
LVDP·HR in this model. The contractile system is also
the major determinant of V˙O2. Both high [lactate] and
low pH reduce contractility in hearts perfused under
saturating conditions, but a load of 20 mM [lactate] is
required to cause the same decline of contractility
caused by 59 nM H1. On return to control conditions,
lactate-challenged hearts exhibit steady decline of both
LVDP and LVDP·HR, as opposed to partial recovery in
H1-challenged hearts. The lactate challenge therefore
induces irreversible injury, in contrast with the par-
tially reversible injury induced by high [H1]. The
former finding is in contrast with the reversible effect of
high [lactate] on isolated cardiac papillary fibers (3),
but in those experiments the time duration of exposure
to high [lactate] was ,20 s at 22°C. Figure 2A shows
that LVDP stabilizes after the H1 challenge is removed
from the combined high [lactate] 1 high [H1] challenge.
The fact that LVDP does not continue to decline may be
caused by offsetting effects of lactate decreasing
ventricular function and improving ventricular func-
tion because of the removal of the H1 challenge. As
the depressions caused by high [lactate] and high
[lactate] 1 high [H1] are similar (compare Fig. 1A with
Fig. 2A), it appears that the effects of the two chal-
lenges are not additive.
The separate effects of high [H1] and high [lactate] in
normally perfused hearts has not been the subject of
extensive investigation. Drake-Holland et al. (9) first
showed that 4.6 mM lactate does not affect O2 consump-
tion in the presence of palmitate and glucose. Karmazyn
(14) showed that 20 mM [lactate] depresses force
development by 24%. Cross et al. (8) reported a nonsig-
nificant depression of LVDP by 21% in the presence of
10 mM [lactate]. Hogan et al. (13) reported, in a model
of in situ dog muscle perfused with [lactate] 10 mM
higher than baseline, a decrease of developed tension
by 15%. A key finding in the present study is that, in
H1-challenged hearts, the 30% decline of LVDP·HR is
accompanied by a 15% decline of V˙O2. In contrast, in
lactate-challenged hearts, the 25% decline of LVDP·HR
occurs at constant V˙O2. Thus, in the presence of compro-
mised function caused by high [lactate], significantly
more O2 is consumed per unit contractility (higher
V˙O2-to-LVDP·HR ratio).
The latter observation is puzzling, because it is not
likely that the extra V˙O2 is directed to synthesize more
ATP. The observed feature can thus be explained either
with decreased bioenergetic efficiency or with increased
ATP consumption in paths not linked to contraction.
The first hypothesis might involve impaired phosphory-
lative coupling efficiency, possibly because high cell
[lactate] dissipates the H1 gradient created by the
electron transport chain via the lactate-H1 cotransport
protein on the inner mitochondrial membrane (12).
However, such an effect would only be transient be-
cause once mitochondrial lactate equilibrates with cyto-
solic lactate, there would be no further impact. Alterna-
tively, high cell [lactate] might have decreased the
contraction coupling efficiency, but direct effects of
lactate (up to 50 mM) on steady-state isometric force of
contraction in rabbit fast and slow skeletal muscle
fibers were excluded (6). As for the second hypothesis,
exposure of ventricular myocytes to 20 mM lactate was
shown to increase the amplitude of Ca21 transients by
18% (5). The subsequent increased Ca21 load would
have increased the O2 cost to pump out Ca21. Alterna-
tively, the higher O2 cost of contraction might be
secondary either to a high NADH-to-NAD1 ratio that
inhibits glycolysis (8) or to the inhibition of Na1/H1
exchange (14), which increases the intracellular Ca21
load and hence the cost to pump out Ca21. As a matter
of fact, our study is certainly not conclusive and is being
followed by additional ones that examine in detail the
various hypotheses.
In conclusion, both H1 and the lactate anion depress
myocardial contractility even in non-O2-limited hearts,
but our results show that different mechanisms are
involved. For example, the various myocardial func-
tions respond differently to the same lactate or H1
loads. In principle, the effect of H1 can be attributed to
an allosteric-like inhibition of key enzymes. However,
high [lactate] irreversibly impairs contractility, per-
haps because the lactate-associated Ca21 overload lim-
its the mitochondrial function.
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